Cart
sales@molnova.com
Metyrosine
CAS No. 672-87-7
Metyrosine ( α-Methyltyrosine )
Catalog No. M24683 CAS No. 672-87-7
Metyrosine is an antihypertensive drug and could be used as a tyrosine hydroxylase inhibitor.Metyrosine significantly inhibits high COX-2 activity.?Metyrosine is a very effective agent for blood pressure control.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 35 | In Stock |
|
| 50MG | 50 | In Stock |
|
| 100MG | 72 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMetyrosine
-
NoteResearch use only, not for human use.
-
Brief DescriptionMetyrosine is an antihypertensive drug and could be used as a tyrosine hydroxylase inhibitor.Metyrosine significantly inhibits high COX-2 activity.?Metyrosine is a very effective agent for blood pressure control.
-
DescriptionMetyrosine is an antihypertensive drug and could be used as a tyrosine hydroxylase inhibitor.Metyrosine significantly inhibits high COX-2 activity.?Metyrosine is a very effective agent for blood pressure control.
-
Synonymsα-Methyltyrosine
-
PathwayChromatin/Epigenetic
-
TargetCOX
-
RecptorCOX-2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number672-87-7
-
Formula Weight195.2
-
Molecular FormulaC10H13NO3
-
Purity>98% (HPLC)
-
SolubilityWater:2 mg/mL (10.24 mM)
-
SMILESC[C@](C(O)=O)(N)CC1=CC=C(O)C=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Garg MK, et al. Medical management of pheochromocytoma: Role of the endocrinologist. Indian J Endocrinol Metab. 2011;15 Suppl 4(Suppl4):S329‐S336.
molnova catalog
related products
-
Hederagenin
Hederagenin is a triterpenoid saponin inhibiting LPS-stimulated expression of iNOS, COX-2, and NF-κB.
-
CAY10404
CAY10404 is a potent and highly selective inhibitor of COX-2 and COX-1. It is also a potent inhibitor of PKB/Akt and MAPK signalling pathways and induces apoptosis in NSCLC cells, with analgesic, anti-inflammatory and anti-cancer activities.
-
Dexketoprofen tromet...
Dexketoprofen trometamol is a modified non-selective COX inhibitor with a rapid onset of action that is available as both oral and parenteral formulations.
